Atossa Therapeutics
ATOS
#10726
Rank
NZ$42.82 M
Marketcap
NZ$4.29
Share price
1.26%
Change (1 day)
163.69%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -NZ$65.51 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$61.92 Million a decrease over its 2024 earnings that were of -NZ$45.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$65.51 Million5.79%
2025 -NZ$61.92 Million36.33%
2024 -NZ$45.42 Million-15.25%
2023 -NZ$53.6 Million11.62%
2022 -NZ$48.02 Million30.84%
2021 -NZ$36.7 Million15.58%
2020 -NZ$31.75 Million3.41%
2019 -NZ$30.71 Million51.16%
2018 -NZ$20.31 Million40.41%
2017 -NZ$14.47 Million27.54%
2016 -NZ$11.35 Million-47.49%
2015 -NZ$21.6 Million-17.25%
2014 -NZ$26.11 Million35.91%
2013 -NZ$19.21 Million112.3%
2012 -NZ$9.05 Million46.53%
2011 -NZ$6.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.67 B-69,600.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.50 B-3,823.25%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.60 B-3,974.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$74.22 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$92.55 Million 37.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.97 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA